skip to main content

Psoriasis — SCE Dermatology MCQ

Instant feedback + full explanation. One question, done properly.

HardInflammatory DermatosesPsoriasisSCE Dermatology

A 30-year-old woman with psoriasis and a BMI of 42 is being considered for weight management as part of her psoriasis care. What is the evidence regarding weight loss and psoriasis severity?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: EWeight loss of ≥5% body weight is associated with significant improvement in psoriasis severity and improved response to systemic therapy

The best answer is “Weight loss of ≥5% body weight is associated with significant improvement in psoriasis severity and improved response to systemic therapy”. NICE recommends treatment matched to severity, high-impact sites, functional burden, comorbidity and prior response; narrowband UVB is a finite specialist option for plaque or guttate psoriasis that topical therapy cannot control. The alternatives “surgical weight loss affects psoriasis, after clinicopathological correlation, after specialist assessment, when the full phenotype supports it, within an appropriate UK pathway”, “Weight loss has no effect on psoriasis, after specialist assessment, when the full phenotype supports it, within an appropriate UK pathway”, “Weight loss worsens psoriasis, when the full phenotype supports it, within an appropriate UK pathway, after clinicopathological correlation”, “diet affects psoriasis, not exercise, within an appropriate UK pathway, after clinicopathological correlation, after specialist assessment, when the full phenotype supports it” are clinically adjacent possibilities, but they do not fit the defining morphology, distribution, histopathology, risk signal or management sequence in this stem.

Reference: NICE CG153 psoriasis recommendations: https://www.nice.org.uk/guidance/cg153/chapter/Recommendations